Literature DB >> 12754538

Plasma and red blood cells membrane lipid concentration of sickle cell disease patients.

Zuhair M Marzouki1, Samir M Khoja.   

Abstract

OBJECTIVE: The present study aimed to determine the concentration of plasma and red blood cells (RBCs) membrane lipids in Saudi sickle cell disease (SCD) patients.
METHODS: This study was carried out at the Hematology Clinic, King Abdul-Aziz University Hospital, Jeddah, Kingdom of Saudi Arabia from October 1998 to October 1999. Lipid concentrations were determined in plasma and RBC membrane of 81 SCD patients and 66 normal healthy matched individuals (control). Different lipid parameters were measured according to standardized enzymatic assay methods.
RESULTS: The plasma concentrations of total cholesterol and low density lipoprotein cholesterol of SCD patients were significantly decreased (p<0.001), whereas the plasma concentrations of high density lipoprotein phospholipids were significantly increased (p<0.001). The plasma concentrations of apo A and apo B were significantly decreased (p<0.001) in SCD patients. However, the concentration of total cholesterol of RBC membrane was significantly increased (p<0.001) in SCD patients, while the phospholipid content was significantly decreased (p<0.001).
CONCLUSION: The significant increase of RBC membrane cholesterol concentration in SCD patients possibly is responsible to the change in RBC membrane fluidity that may play a direct role in the sickling phenomenon of RBCs in SCD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12754538

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  8 in total

1.  Lipoprotein subfraction profile and HDL-associated enzymes in sickle cell disease patients.

Authors:  Oktay H Ozturk; Yesim Can; Zafer Yonden; Sedat Motor; Gonul Oktay; Hasan Kaya; Mutay Aslan
Journal:  Lipids       Date:  2013-10-11       Impact factor: 1.880

2.  Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension.

Authors:  Suzana Zorca; Lita Freeman; Mariana Hildesheim; Darlene Allen; Alan T Remaley; James G Taylor; Gregory J Kato
Journal:  Br J Haematol       Date:  2010-03-08       Impact factor: 6.998

3.  Defects in postabsorptive plasma homeostasis of fatty acids in sickle cell disease.

Authors:  Maciej S Buchowski; Larry L Swift; Sylvie A Akohoue; Sadhna M Shankar; Paul J Flakoll; Naji Abumrad
Journal:  JPEN J Parenter Enteral Nutr       Date:  2007 Jul-Aug       Impact factor: 4.016

4.  Plasma Lipids and Lipoproteins in Sickle Cell Disease Patients in the Northern West Bank, Palestine.

Authors:  Fekri Samarah; Mahmoud A Srour; Kamal Dumaidi
Journal:  Biomed Res Int       Date:  2021-08-04       Impact factor: 3.411

5.  Hydroxyurea therapy mobilises arachidonic Acid from inner cell membrane aminophospholipids in patients with homozygous sickle cell disease.

Authors:  A A Daak; K Ghebremeskel; M I Elbashir; A Bakhita; Z Hassan; M A Crawford
Journal:  J Lipids       Date:  2011-09-15

6.  The influence of decreased levels of high density lipoprotein cholesterol on hematological indices in sickle cell disease patients.

Authors:  Am Emokpae; A Kuliya-Gwarzo
Journal:  Ann Med Health Sci Res       Date:  2014-03

7.  Normal Non-HDL Cholesterol, Low Total Cholesterol, and HDL Cholesterol Levels in Sickle Cell Disease Patients in the Steady State: A Case-Control Study of Tema Metropolis.

Authors:  Richard K D Ephraim; Patrick Adu; Edem Ake; Hope Agbodzakey; Prince Adoba; Obed Cudjoe; Clement Agoni
Journal:  J Lipids       Date:  2016-12-18

8.  Association of oxidative stress markers with atherogenic index of plasma in adult sickle cell nephropathy.

Authors:  M A Emokpae; P O Uadia
Journal:  Anemia       Date:  2012-04-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.